The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $44.73

Today's change-0.04 -0.09%
Updated March 24 4:01 PM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $44.73

Today's change-0.04 -0.09%
Updated March 24 4:01 PM EDT. Delayed by at least 15 minutes.

Abbott Laboratories down slightly

Abbott Laboratories closed down just (U.S.)$0.04 Friday to (U.S.)$44.73. Shares have lost 1.02% over the last five days, but sit 2.42% below their 52-week high. This security has underperformed the S&P 500 by 5.36% during the last year.

Key company metrics

  • Open(U.S.) $44.76
  • Previous close(U.S.) $44.77
  • High(U.S.) $45.15
  • Low(U.S.) $44.60
  • Bid / Ask-- / --
  • YTD % change+16.45%
  • Volume4,753,163
  • Average volume (10-day)6,315,536
  • Average volume (1-month)7,314,210
  • Average volume (3-month)8,679,735
  • 52-week range(U.S.) $36.76 to (U.S.) $45.84
  • Beta1.41
  • Trailing P/E62.47×
  • P/E 1 year forward18.24×
  • Forward PEG1.62×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield2.37%
  • Trailing EPS(U.S.) $0.72
Updated March 24 4:01 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue5,3335,3025,3334,885
Total other revenue--------
Total revenue5,3335,3025,3334,885
Gross profit3,0233,0173,0522,746
Total cost of revenue2,3102,2852,2812,139
Total operating expense4,3854,4054,5174,361
Selling / general / administrative1,6061,6181,7461,683
Research & development338352348379
Depreciation / amortization121140145144
Interest expense (income), net operating--------
Unusual expense (income)1010-316
Other operating expenses, total--------
Operating income948897816524
Interest income (expense), net non-operating-153-117-103-58
Gain (loss) on sale of assets--------
Other--------
Income before tax875-1797152
Income after tax765-35759956
Income tax, total110178116-54
Net income798-329615316
Total adjustments to net income--------
Net income before extra. items765-35759956
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items765-35759956
Inc. avail. to common incl. extra. items798-329615316
Diluted net income798-329615316
Dilution adjustment--000
Diluted weighted average shares1,4841,4761,4801,484
Diluted EPS excluding extraordinary itemsvalue per share0.52-0.240.400.04
Dividends per sharevalue per share0.260.260.260.26
Diluted normalized EPSvalue per share0.52-0.240.400.04